Sintx Technologies (SINT) EBITDA Margin Growth (5y) (2018 - 2026)
Sintx Technologies (SINT) EBITDA Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Sintx Technologies | 17,274.80 | -1.87 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 196,892.00 |
| Dec 31, 2025 | 113,000.00 |
| Sep 30, 2025 | 206,581.00 |
| Jun 30, 2025 | -79,235.00 |
| Mar 31, 2025 | 24,985.00 |
| Dec 31, 2024 | 33,163.00 |
| Sep 30, 2024 | 18,066.00 |
| Jun 30, 2024 | 59,589.00 |
| Mar 31, 2024 | 131,815.00 |
| Jun 30, 2023 | -58,861.00 |
| Mar 31, 2023 | -56,254.00 |
| Dec 31, 2022 | -29,792.00 |
| Sep 30, 2022 | -58,885.00 |
| Jun 30, 2022 | -110,584.00 |
| Mar 31, 2022 | -216,401.00 |
| Dec 31, 2021 | -147,876.00 |
| Sep 30, 2021 | -108,707.00 |
| Jun 30, 2021 | -227,744.00 |
| Mar 31, 2021 | -275,335.00 |
| Dec 31, 2020 | -187,763.00 |